Showing results (101-110 of 6,499) with videos related to

Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|February 28, 2012
Enhanced activation of human dendritic cells by silencing SOCS1 and activating TLRs simultaneouslyJing Zhang, Jinpu Yu, Lili Yang, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2012
Recombinant IgE antibody engineering to target EGFREdzard Spillner, Melanie Plum, Simon Blank, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2012
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancerLiangrong Shi, Qi Zhou, Jun Wu, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2012
Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survivalYuan Zhuang, Liu-Sheng Peng, Yong-Liang Zhao, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2012
Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccineHui-Ming Chen, Pi-Hsueh Wang, Swey-Shen Chen, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2012
Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parametersErik H J G Aarntzen, I Jolanda M de Vries, Joop H Göertz, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2016
4-1BB agonism: adding the accelerator to cancer immunotherapyCariad Chester, Siddhant Ambulkar, Holbrook E Kohrt
Cancer Immunology, Immunotherapy : CII|January 1, 1989
The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cellsJ L Collins, M S Kao
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing miceI H Ames, G M Gagne, A M Garcia, et al.
Pageof 650